New meningitis B vaccine set to be licensed for use in UK
A vaccine to protect children against one of the deadliest and most common forms of meningitis is set to be licensed for use in the UK.
More than 1,500 people contract meningitis B each year and one in 10 of them die.
It is thought the new drug could save thousands of lives.
Sian Lloyd reports.